Baker McKenzie advised Crisalix SA ("Crisalix"), a leading provider of 3D simulation technology for the aesthetic market, and its shareholders on its acquisition by BID Equity. The acquisition aims to combine Crisalix's technological expertise with BID Equity's financial resources to promote international growth and innovative product development.
Headquartered in Lausanne, Switzerland, Crisalix offers cloud-based software solutions that enhance patient decision-making and build trust among medical professionals. BID Equity, based in Hamburg, engages in operational value creation through buy and build, internationalization and by advancing its portfolio companies' software-specific capabilities.
Baker McKenzie advised Crisalix on all legal and tax matters related to this transaction.
The team was led by M&A Partner Manuel Meyer and consisted of:
Baker McKenzie Switzerland, Zurich office:
Vinzenz Sutter and Hesam Mirzai (associates, M&A), Danijela Mrdak (trainee lawyer), Andrea Bolliger (counsel, tax) and Pascale Schwizer (associate, tax)
Baker McKenzie Germany, Munich office:
Jon Marcus Meese (partner, M&A, Corporate Reorganizations) and Eva Kriechbaumer (associate, M&A, Corporate Reorganizations)
